Sign in

    Andrew Steinhardt • Canaccord Genuity

    Andrew Steinhardt is an Equity Research Senior Associate at Canaccord Genuity, specializing in equity research within the financial sector with a primary focus on supporting senior analysts in covering public company stocks. He is involved in the analysis and coverage of companies across a variety of industries, contributing to deep-dive reports and investment recommendations, though specific company names and individual performance metrics are not publicly available. Steinhardt began his career in the finance industry in recent years, holding his current role with Canaccord Genuity in New York, and is registered as a broker with FINRA under CRD# 7927419. His professional credentials include compliance with FINRA regulatory requirements, but no public recognition or ranking information could be verified.

    Andrew Steinhardt's questions to Bioceres Crop Solutions Corp (BIOX) leadership

    Andrew Steinhardt's questions to Bioceres Crop Solutions Corp (BIOX) leadership • Q1 2025

    Question

    Andrew Steinhardt asked for a timeline on securing an HB4 distribution partner and whether commodity prices or interest rates are bigger recovery drivers.

    Answer

    CEO Federico Trucco declined to give a specific date for an HB4 partner announcement but noted good traction. He identified the potential removal of Argentina's soybean export tax as a more significant recovery driver than commodity prices or interest rates, calling it a realistic possibility that could unlock substantial value for farmers.

    Ask Fintool Equity Research AI